This report aims to provide a comprehensive presentation of the global market for CAR-T Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR-T Therapy. This report contains market size and forecasts of CAR-T Therapy in global, including the following market information:
Global CAR-T Therapy Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global CAR-T Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
CD19 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of CAR-T Therapy include Novartis AG, Kite Pharma, Pfizer, Juno Therapeutics, Celgene Corporation, CARsgen Therapeutics, Sorrento Therapeutics, Legend Biotech and Atara Biotherapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the CAR-T Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CAR-T Therapy Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global CAR-T Therapy Market Segment Percentages, by Type, 2022 (%)
CD19
CD22
Other
Global CAR-T Therapy Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global CAR-T Therapy Market Segment Percentages, by Application, 2022 (%)
Acute Lymphocytic Leukemia
Diffuse Large B Cell Lymphoma
Follicular Lymphoma
Chronic Lymphocytic Leukemia
Multiple Myeloma
Other
Global CAR-T Therapy Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global CAR-T Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CAR-T Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies CAR-T Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Kite Pharma
Pfizer
Juno Therapeutics
Celgene Corporation
CARsgen Therapeutics
Sorrento Therapeutics
Legend Biotech
Atara Biotherapeutics
Aurora Biopharma
Autolus Therapeutics PLC
Bluebird
Carina Biotech
Outline of Major Chapters:
Chapter 1: Introduces the definition of CAR-T Therapy, market overview.
Chapter 2: Global CAR-T Therapy market size in revenue.
Chapter 3: Detailed analysis of CAR-T Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CAR-T Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 CAR-T Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CAR-T Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CAR-T Therapy Overall Market Size
2.1 Global CAR-T Therapy Market Size: 2022 VS 2032
2.2 Global CAR-T Therapy Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CAR-T Therapy Players in Global Market
3.2 Top Global CAR-T Therapy Companies Ranked by Revenue
3.3 Global CAR-T Therapy Revenue by Companies
3.4 Top 3 and Top 5 CAR-T Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies CAR-T Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 CAR-T Therapy Players in Global Market
3.6.1 List of Global Tier 1 CAR-T Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 CAR-T Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global CAR-T Therapy Market Size Markets, 2022 & 2032
4.1.2 CD19
4.1.3 CD22
4.1.4 Other
4.2 By Type - Global CAR-T Therapy Revenue & Forecasts
4.2.1 By Type - Global CAR-T Therapy Revenue, 2018-2023
4.2.2 By Type - Global CAR-T Therapy Revenue, 2024-2032
4.2.3 By Type - Global CAR-T Therapy Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global CAR-T Therapy Market Size, 2022 & 2032
5.1.2 Acute Lymphocytic Leukemia
5.1.3 Diffuse Large B Cell Lymphoma
5.1.4 Follicular Lymphoma
5.1.5 Chronic Lymphocytic Leukemia
5.1.6 Multiple Myeloma
5.1.7 Other
5.2 By Application - Global CAR-T Therapy Revenue & Forecasts
5.2.1 By Application - Global CAR-T Therapy Revenue, 2018-2023
5.2.2 By Application - Global CAR-T Therapy Revenue, 2024-2032
5.2.3 By Application - Global CAR-T Therapy Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global CAR-T Therapy Market Size, 2022 & 2032
6.2 By Region - Global CAR-T Therapy Revenue & Forecasts
6.2.1 By Region - Global CAR-T Therapy Revenue, 2018-2023
6.2.2 By Region - Global CAR-T Therapy Revenue, 2024-2032
6.2.3 By Region - Global CAR-T Therapy Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America CAR-T Therapy Revenue, 2018-2032
6.3.2 US CAR-T Therapy Market Size, 2018-2032
6.3.3 Canada CAR-T Therapy Market Size, 2018-2032
6.3.4 Mexico CAR-T Therapy Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe CAR-T Therapy Revenue, 2018-2032
6.4.2 Germany CAR-T Therapy Market Size, 2018-2032
6.4.3 France CAR-T Therapy Market Size, 2018-2032
6.4.4 U.K. CAR-T Therapy Market Size, 2018-2032
6.4.5 Italy CAR-T Therapy Market Size, 2018-2032
6.4.6 Russia CAR-T Therapy Market Size, 2018-2032
6.4.7 Nordic Countries CAR-T Therapy Market Size, 2018-2032
6.4.8 Benelux CAR-T Therapy Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia CAR-T Therapy Revenue, 2018-2032
6.5.2 China CAR-T Therapy Market Size, 2018-2032
6.5.3 Japan CAR-T Therapy Market Size, 2018-2032
6.5.4 South Korea CAR-T Therapy Market Size, 2018-2032
6.5.5 Southeast Asia CAR-T Therapy Market Size, 2018-2032
6.5.6 India CAR-T Therapy Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America CAR-T Therapy Revenue, 2018-2032
6.6.2 Brazil CAR-T Therapy Market Size, 2018-2032
6.6.3 Argentina CAR-T Therapy Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CAR-T Therapy Revenue, 2018-2032
6.7.2 Turkey CAR-T Therapy Market Size, 2018-2032
6.7.3 Israel CAR-T Therapy Market Size, 2018-2032
6.7.4 Saudi Arabia CAR-T Therapy Market Size, 2018-2032
6.7.5 UAE CAR-T Therapy Market Size, 2018-2032
7 CAR-T Therapy Companies Profiles
7.1 Novartis AG
7.1.1 Novartis AG Company Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG CAR-T Therapy Major Product Offerings
7.1.4 Novartis AG CAR-T Therapy Revenue in Global Market (2018-2023)
7.1.5 Novartis AG Key News & Latest Developments
7.2 Kite Pharma
7.2.1 Kite Pharma Company Summary
7.2.2 Kite Pharma Business Overview
7.2.3 Kite Pharma CAR-T Therapy Major Product Offerings
7.2.4 Kite Pharma CAR-T Therapy Revenue in Global Market (2018-2023)
7.2.5 Kite Pharma Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer CAR-T Therapy Major Product Offerings
7.3.4 Pfizer CAR-T Therapy Revenue in Global Market (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Juno Therapeutics
7.4.1 Juno Therapeutics Company Summary
7.4.2 Juno Therapeutics Business Overview
7.4.3 Juno Therapeutics CAR-T Therapy Major Product Offerings
7.4.4 Juno Therapeutics CAR-T Therapy Revenue in Global Market (2018-2023)
7.4.5 Juno Therapeutics Key News & Latest Developments
7.5 Celgene Corporation
7.5.1 Celgene Corporation Company Summary
7.5.2 Celgene Corporation Business Overview
7.5.3 Celgene Corporation CAR-T Therapy Major Product Offerings
7.5.4 Celgene Corporation CAR-T Therapy Revenue in Global Market (2018-2023)
7.5.5 Celgene Corporation Key News & Latest Developments
7.6 CARsgen Therapeutics
7.6.1 CARsgen Therapeutics Company Summary
7.6.2 CARsgen Therapeutics Business Overview
7.6.3 CARsgen Therapeutics CAR-T Therapy Major Product Offerings
7.6.4 CARsgen Therapeutics CAR-T Therapy Revenue in Global Market (2018-2023)
7.6.5 CARsgen Therapeutics Key News & Latest Developments
7.7 Sorrento Therapeutics
7.7.1 Sorrento Therapeutics Company Summary
7.7.2 Sorrento Therapeutics Business Overview
7.7.3 Sorrento Therapeutics CAR-T Therapy Major Product Offerings
7.7.4 Sorrento Therapeutics CAR-T Therapy Revenue in Global Market (2018-2023)
7.7.5 Sorrento Therapeutics Key News & Latest Developments
7.8 Legend Biotech
7.8.1 Legend Biotech Company Summary
7.8.2 Legend Biotech Business Overview
7.8.3 Legend Biotech CAR-T Therapy Major Product Offerings
7.8.4 Legend Biotech CAR-T Therapy Revenue in Global Market (2018-2023)
7.8.5 Legend Biotech Key News & Latest Developments
7.9 Atara Biotherapeutics
7.9.1 Atara Biotherapeutics Company Summary
7.9.2 Atara Biotherapeutics Business Overview
7.9.3 Atara Biotherapeutics CAR-T Therapy Major Product Offerings
7.9.4 Atara Biotherapeutics CAR-T Therapy Revenue in Global Market (2018-2023)
7.9.5 Atara Biotherapeutics Key News & Latest Developments
7.10 Aurora Biopharma
7.10.1 Aurora Biopharma Company Summary
7.10.2 Aurora Biopharma Business Overview
7.10.3 Aurora Biopharma CAR-T Therapy Major Product Offerings
7.10.4 Aurora Biopharma CAR-T Therapy Revenue in Global Market (2018-2023)
7.10.5 Aurora Biopharma Key News & Latest Developments
7.11 Autolus Therapeutics PLC
7.11.1 Autolus Therapeutics PLC Company Summary
7.11.2 Autolus Therapeutics PLC Business Overview
7.11.3 Autolus Therapeutics PLC CAR-T Therapy Major Product Offerings
7.11.4 Autolus Therapeutics PLC CAR-T Therapy Revenue in Global Market (2018-2023)
7.11.5 Autolus Therapeutics PLC Key News & Latest Developments
7.12 Bluebird
7.12.1 Bluebird Company Summary
7.12.2 Bluebird Business Overview
7.12.3 Bluebird CAR-T Therapy Major Product Offerings
7.12.4 Bluebird CAR-T Therapy Revenue in Global Market (2018-2023)
7.12.5 Bluebird Key News & Latest Developments
7.13 Carina Biotech
7.13.1 Carina Biotech Company Summary
7.13.2 Carina Biotech Business Overview
7.13.3 Carina Biotech CAR-T Therapy Major Product Offerings
7.13.4 Carina Biotech CAR-T Therapy Revenue in Global Market (2018-2023)
7.13.5 Carina Biotech Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. CAR-T Therapy Market Opportunities & Trends in Global Market
Table 2. CAR-T Therapy Market Drivers in Global Market
Table 3. CAR-T Therapy Market Restraints in Global Market
Table 4. Key Players of CAR-T Therapy in Global Market
Table 5. Top CAR-T Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global CAR-T Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global CAR-T Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies CAR-T Therapy Product Type
Table 9. List of Global Tier 1 CAR-T Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CAR-T Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global CAR-T Therapy Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - CAR-T Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - CAR-T Therapy Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global CAR-T Therapy Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - CAR-T Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - CAR-T Therapy Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global CAR-T Therapy Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global CAR-T Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global CAR-T Therapy Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America CAR-T Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America CAR-T Therapy Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe CAR-T Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe CAR-T Therapy Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia CAR-T Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia CAR-T Therapy Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America CAR-T Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America CAR-T Therapy Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa CAR-T Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa CAR-T Therapy Revenue, (US$, Mn), 2024-2032
Table 30. Novartis AG Company Summary
Table 31. Novartis AG CAR-T Therapy Product Offerings
Table 32. Novartis AG CAR-T Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis AG Key News & Latest Developments
Table 34. Kite Pharma Company Summary
Table 35. Kite Pharma CAR-T Therapy Product Offerings
Table 36. Kite Pharma CAR-T Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Kite Pharma Key News & Latest Developments
Table 38. Pfizer Company Summary
Table 39. Pfizer CAR-T Therapy Product Offerings
Table 40. Pfizer CAR-T Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Pfizer Key News & Latest Developments
Table 42. Juno Therapeutics Company Summary
Table 43. Juno Therapeutics CAR-T Therapy Product Offerings
Table 44. Juno Therapeutics CAR-T Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Juno Therapeutics Key News & Latest Developments
Table 46. Celgene Corporation Company Summary
Table 47. Celgene Corporation CAR-T Therapy Product Offerings
Table 48. Celgene Corporation CAR-T Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Celgene Corporation Key News & Latest Developments
Table 50. CARsgen Therapeutics Company Summary
Table 51. CARsgen Therapeutics CAR-T Therapy Product Offerings
Table 52. CARsgen Therapeutics CAR-T Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. CARsgen Therapeutics Key News & Latest Developments
Table 54. Sorrento Therapeutics Company Summary
Table 55. Sorrento Therapeutics CAR-T Therapy Product Offerings
Table 56. Sorrento Therapeutics CAR-T Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Sorrento Therapeutics Key News & Latest Developments
Table 58. Legend Biotech Company Summary
Table 59. Legend Biotech CAR-T Therapy Product Offerings
Table 60. Legend Biotech CAR-T Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Legend Biotech Key News & Latest Developments
Table 62. Atara Biotherapeutics Company Summary
Table 63. Atara Biotherapeutics CAR-T Therapy Product Offerings
Table 64. Atara Biotherapeutics CAR-T Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Atara Biotherapeutics Key News & Latest Developments
Table 66. Aurora Biopharma Company Summary
Table 67. Aurora Biopharma CAR-T Therapy Product Offerings
Table 68. Aurora Biopharma CAR-T Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Aurora Biopharma Key News & Latest Developments
Table 70. Autolus Therapeutics PLC Company Summary
Table 71. Autolus Therapeutics PLC CAR-T Therapy Product Offerings
Table 72. Autolus Therapeutics PLC CAR-T Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Autolus Therapeutics PLC Key News & Latest Developments
Table 74. Bluebird Company Summary
Table 75. Bluebird CAR-T Therapy Product Offerings
Table 76. Bluebird CAR-T Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Bluebird Key News & Latest Developments
Table 78. Carina Biotech Company Summary
Table 79. Carina Biotech CAR-T Therapy Product Offerings
Table 80. Carina Biotech CAR-T Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. Carina Biotech Key News & Latest Developments
List of Figures
Figure 1. CAR-T Therapy Segment by Type in 2022
Figure 2. CAR-T Therapy Segment by Application in 2022
Figure 3. Global CAR-T Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global CAR-T Therapy Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global CAR-T Therapy Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CAR-T Therapy Revenue in 2022
Figure 8. By Type - Global CAR-T Therapy Revenue Market Share, 2018-2032
Figure 9. By Application - Global CAR-T Therapy Revenue Market Share, 2018-2032
Figure 10. By Type - Global CAR-T Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global CAR-T Therapy Revenue Market Share, 2018-2032
Figure 12. By Application - Global CAR-T Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global CAR-T Therapy Revenue Market Share, 2018-2032
Figure 14. By Region - Global CAR-T Therapy Revenue Market Share, 2018-2032
Figure 15. By Country - North America CAR-T Therapy Revenue Market Share, 2018-2032
Figure 16. US CAR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 17. Canada CAR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico CAR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe CAR-T Therapy Revenue Market Share, 2018-2032
Figure 20. Germany CAR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 21. France CAR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. CAR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 23. Italy CAR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 24. Russia CAR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries CAR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux CAR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia CAR-T Therapy Revenue Market Share, 2018-2032
Figure 28. China CAR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 29. Japan CAR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea CAR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia CAR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 32. India CAR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America CAR-T Therapy Revenue Market Share, 2018-2032
Figure 34. Brazil CAR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina CAR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa CAR-T Therapy Revenue Market Share, 2018-2032
Figure 37. Turkey CAR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 38. Israel CAR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia CAR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 40. UAE CAR-T Therapy Revenue, (US$, Mn), 2018-2032
Figure 41. Novartis AG CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Kite Pharma CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Pfizer CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Juno Therapeutics CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Celgene Corporation CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. CARsgen Therapeutics CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Sorrento Therapeutics CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Legend Biotech CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Atara Biotherapeutics CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Aurora Biopharma CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Autolus Therapeutics PLC CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Bluebird CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Carina Biotech CAR-T Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
